Abstracts

Treating the inflammation of rheumatoid arthritis early leads to less disability and improved patient outcomes.

Rheumatosphere is an initiative started in Glasgow, UK, in 2012; its aim is to raise awareness about arthritis and arthritis-related research.

Understanding the interplay between the immune system and gastrointestinal tract microbiota is an evolving area of research.

Immunisation of biological drugs can result in reduced efficacy of treatment and an increased risk of adverse effects.

Fibromyalgia is characterised by chronic musculoskeletal pain, autonomic nervous system dysfunction, and disturbed sleep.

The OMERACT gout group has, for several years, been working towards a model for evaluating a biomarker as surrogate endpoint for clinically relevant outcomes.

It has been estimated that almost half of gout patients in Europe are obese.

Immune checkpoint inhibitors targeting cytotoxic T-lymphocyte–associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have demonstrated…